Affimed Announces Presentation of Data on Genentech’s RO7297089 and AFM24, Both Innate Cell Engagers Developed from Affimed’s ROCK® Platform, at AACR Virtual Annual Meeting II

NEXT STORY
Point of Care (POC) Molecular Diagnostics Market Worth $2.39 Billion by 2027, Growing at a CAGR of 13.2% from 2019- Pre and Post COVID-19 Market Opportunity Analysis and Industry Forecasts by Meticulous Research®
PREV STORY
Mersana Therapeutics Presents Preclinical Data from its Innovative Dolasynthen and Immunosynthen ADC Platforms at American Association for Cancer Research 2020 Virtual Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Affimed Announces Presentation of Data on Genentech’s RO7297089 and AFM24, Both Innate Cell Engagers Developed from Affimed’s ROCK® Platform, at AACR Virtual Annual Meeting II

NEXT STORY
Point of Care (POC) Molecular Diagnostics Market Worth $2.39 Billion by 2027, Growing at a CAGR of 13.2% from 2019- Pre and Post COVID-19 Market Opportunity Analysis and Industry Forecasts by Meticulous Research®
PREV STORY
Mersana Therapeutics Presents Preclinical Data from its Innovative Dolasynthen and Immunosynthen ADC Platforms at American Association for Cancer Research 2020 Virtual Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Atossa Therapeutics Announces Ovarian Cancer Patient has Begun Treatment with Oral Endoxifen under FDA’s Expanded Access Pathway

author_avatar
NASDAQ Market News

NANOBIOTIX announces first positive Human data showing that NBTXR3 could become a backbone in Immuno-Oncology

   NANOBIOTIX ANNOUNCES FIRST POSITIVE HUMAN DATA SHOWING THAT NBTXR3 COULD BECOME A BACKBONE ...

author_avatar
NASDAQ Market News

Dr. Judith K. Glann, DNP/MSN/ACNP-BC/CCRN, is appointed to the American Health Council for Best in Nursing

NEW YORK, Aug. 21, 2017 (GLOBE NEWSWIRE) -- Currently a Trauma/Surgical ICU Critical Care ...

author_avatar
NASDAQ Market News